ATE553767T1 - Arzneizubereitung zur behandlung von muskulärer atrophie und myasthenia gravis und die herstellung derselben - Google Patents

Arzneizubereitung zur behandlung von muskulärer atrophie und myasthenia gravis und die herstellung derselben

Info

Publication number
ATE553767T1
ATE553767T1 AT06011553T AT06011553T ATE553767T1 AT E553767 T1 ATE553767 T1 AT E553767T1 AT 06011553 T AT06011553 T AT 06011553T AT 06011553 T AT06011553 T AT 06011553T AT E553767 T1 ATE553767 T1 AT E553767T1
Authority
AT
Austria
Prior art keywords
medicine composition
myasthenia gravis
same
muscular atrophy
parts
Prior art date
Application number
AT06011553T
Other languages
English (en)
Inventor
Yiling Wu
Original Assignee
Hebei Yiling Medicine Res Inst Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hebei Yiling Medicine Res Inst Co Ltd filed Critical Hebei Yiling Medicine Res Inst Co Ltd
Application granted granted Critical
Publication of ATE553767T1 publication Critical patent/ATE553767T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/254—Acanthopanax or Eleutherococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
    • A61K36/296—Epimedium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT06011553T 2006-06-02 2006-06-02 Arzneizubereitung zur behandlung von muskulärer atrophie und myasthenia gravis und die herstellung derselben ATE553767T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06011553A EP1862171B1 (de) 2006-06-02 2006-06-02 Arzneizubereitung zur Behandlung von muskulärer Atrophie und Myasthenia gravis und die Herstellung derselben

Publications (1)

Publication Number Publication Date
ATE553767T1 true ATE553767T1 (de) 2012-05-15

Family

ID=37103080

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06011553T ATE553767T1 (de) 2006-06-02 2006-06-02 Arzneizubereitung zur behandlung von muskulärer atrophie und myasthenia gravis und die herstellung derselben

Country Status (2)

Country Link
EP (1) EP1862171B1 (de)
AT (1) ATE553767T1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102091114B (zh) * 2009-12-15 2014-11-26 河北以岭医药研究院有限公司 一种中药冻干注射剂及其制备方法
CN102716162A (zh) * 2012-07-03 2012-10-10 吉林省宏久生物科技股份有限公司 一种人参二醇组皂苷的制备技术及方法
CN104689025A (zh) * 2015-01-29 2015-06-10 福建广生堂药业股份有限公司 一种具有补肾壮阳、治疗性功能障碍、延缓衰老的中药复方制剂及其制备方法
CN105929055A (zh) * 2016-04-20 2016-09-07 广西壮族自治区梧州食品药品检验所 高效液相色谱法测定清喉利咽颗粒中黄芩苷含量的方法
CN106828425B (zh) * 2017-01-05 2019-04-19 中石化上海工程有限公司 用于中药材输送车自动清洗的方法
CN106822582A (zh) * 2017-02-17 2017-06-13 成都市飞龙水处理技术研究所青白江第分所 一种治疗肾阳不足所致腰膝酸软及头晕耳鸣的中药组合物
CN108794058A (zh) * 2017-10-11 2018-11-13 唐山晶玉功能陶瓷制品有限公司 一种高强度亚微米微孔陶瓷及其制造方法
CN109620849A (zh) * 2019-02-20 2019-04-16 苏州大学 一种用于研究脊髓前角运动神经元轴突再生的小鼠模型

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1057572A (zh) * 1990-06-23 1992-01-08 董承统 制备“速度-力量”型运动饮料的方法
ATE275408T1 (de) * 1995-11-22 2004-09-15 Cheil Je Dang Co Verfahren zur herstellung von rg3 und rg5 ginsenosiden
CN1174066A (zh) * 1997-07-16 1998-02-25 迟经惠 五劳七伤散(脾贤两虚腿细消肾无力)
CN1183980A (zh) * 1997-08-02 1998-06-10 迟经惠 重症肌生力饮
CN1090944C (zh) * 2000-06-14 2002-09-18 邓开仲 防治老年性痴呆和抑郁症的药物及制备工艺
CN1199656C (zh) * 2000-09-08 2005-05-04 姜东海 一种治疗重症肌无力的药物

Also Published As

Publication number Publication date
EP1862171B1 (de) 2012-04-18
EP1862171A1 (de) 2007-12-05

Similar Documents

Publication Publication Date Title
ATE553767T1 (de) Arzneizubereitung zur behandlung von muskulärer atrophie und myasthenia gravis und die herstellung derselben
Peurala et al. Evidence for the effectiveness of walking training on walking and self-care after stroke. A systematic review and meta-analysis of randomized controlled trials
DE60336934D1 (de) Verwendung von igf-1-serumspiegel-erhöhenden indolessigsäure-derivaten zur herstellung eines arzneimittels zur behandlung von verschiedenen krankheiten
EA200602191A1 (ru) 5,5-дизамещённые-2-амино-4-тиазолидиноны и способ их получения, фармацевтическая композиция и способ лечения
RU2015127794A (ru) Введение антисмысловых олигонуклеотидов, комплементарных человеческому аполипопротеину в
WO2013002584A3 (ko) 다중 타겟팅의 상승 효과를 유발하는 유효물질의 조합 및 그 용도
WO2009065406A3 (en) Novel cyclic hydrocarbon compounds for the treatment of diseases
TNSN07208A1 (en) 3,5-DISUBTITUTED AND 3,5,7-TRISUBSTITUTED-3H-OXAZOLO AND 3H-THIAZOLO [4,5-d] PYRIMIDIN-2-ONE COMPOUNDS AND PRODRUGS THEREOF
NZ600094A (en) Method of enhancing muscle protein synthesis
ATE446102T1 (de) Behandlung von gewichtsverlust bei patienten mit entzündlichen darmerkrankungen mittels s. boulardii
WO2008157791A3 (en) Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration using isothiazolopyrimidinones
WO2006009975A3 (en) Histamine to treat disorders affecting muscle function
WO2016190682A3 (ko) 모루신, 구와논 지 또는 상백피를 함유하는 근육 질환 예방 및 치료용 또는 근 기능 개선용 조성물
TW200505880A (en) Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals
DE602004031631D1 (de) Verwendung von betain zur behandlung von claudicatio intermittens
UA35209U (ru) Способ продления жизни человека
WO2006101910A3 (en) Peptide compounds and methods of using peptide compounds to treat conditions affecting the cardiac, pulmonary, and nervous systems
WO2006050451A3 (en) Methods and compositions to treat motor neuron disease
ATE502637T1 (de) Medikamente zur prävention oder behandlung von herzversagen mit einem anticholinergikum
ATE445633T1 (de) Die regeneration von neuronen des zentralen nervensystems stimulierende peptidsubstanz, darauf basierende pharmazeutische zusammensetzung und verfahren zu ihrer anwendung
Powers et al. MIP/MTMR14 and muscle aging
WO2004062626A3 (en) Composition and method for treating age-related disorders
Melo et al. High intensity inspiratory muscle training in patients with traumatic brain injury under mechanical ventilation: preliminary results of a randomized controlled trial
CN102949424A (zh) 一种用于缓解体力疲劳的药物组合物及其制备方法
WO2011018672A8 (en) Methods and substances for stimulating muscle regeneration